Baltimore, MD, United States of America

Ashley Behrens

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Ashley Behrens in Eye Therapeutics

Introduction

Ashley Behrens is a prominent inventor based in Baltimore, MD (US), known for her significant contributions to the field of eye therapeutics. With a total of five patents to her name, she has made remarkable strides in developing innovative drug delivery systems aimed at treating eye disorders.

Latest Patents

Among her latest patents is a groundbreaking invention focused on the sustained delivery of therapeutic agents to an eye compartment. This patent describes compositions and methods for treating eye disorders by administering a drug delivery system that contains a particle with a core and a specialized coating. The coating is designed to present a hydrophilic region to the surrounding environment, enhancing the effectiveness of the therapeutic agent. The invention demonstrates that the eye compartment can exhibit reduced inflammation or intraocular pressure (IOP) after the administration of these advanced drug delivery systems compared to traditional uncoated particles.

Career Highlights

Ashley Behrens is affiliated with The Johns Hopkins University, where she continues to push the boundaries of research and innovation in her field. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from various eye disorders.

Collaborations

Throughout her career, Ashley has collaborated with esteemed colleagues, including Peter John McDonnell and Yasin A Khan, further enhancing the impact of her research and innovations.

Conclusion

Ashley Behrens stands out as a leading inventor in the realm of eye therapeutics, with her innovative approaches promising to transform treatment methodologies. Her contributions are paving the way for advancements in patient care and therapeutic efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…